We also found that GE treatment alone can induce a significant increment of ERα expression regardless of additional TAM treatment (Figure 4 and Additional file 2C), indicating other potential regulatory mechanisms besides the ER pathway may be involved in GE and TAM-enhanced tumor inhibition on ERα-negative breast cancer. Here, ESR1 is linked to breast cancer.